CRH Medical Board of Directors
Composed of accomplished physicians and business leaders, our board of directors is focused on building a company with exceptional medical impact – and ongoing financial success.
Dr. Anthony F. Holler - Chairman of the BoardDr. Holler has been Chairman of the Board of Directors of CRH Medical since December 2005. He also serves as the CEO and Chairman of the Board of Directors for Sunniva Inc.
Prior to joining CRH, Dr. Holler was one of the founders of ID Biomedical Corporation since its inception in 1991. He held a number of executive positions with ID Biomedical, including Chief Executive Officer until the company was acquired by GlaxoSmithKline in December 2005 for $1.7 billion. Dr. Holler was also Chairman of Corriente Resources Inc., which sold for approximately $700 million to CRCC-Tongguan Investment Co. in 2010.
Before his involvement in public markets, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia. He holds a Bachelor of Science degree and a medical degree from the University of British Columbia and is a member of the British Columbia College of Physicians and Surgeons.
Dr. Holler is a member of the following Board Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.
David A. Johnson, MD, MACG, FASGE, FACP - DirectorDr. Johnson has been an Independent Director of CRH Medical since June of 2010. Since 1989, he is also a partner of Gastrointestinal and Liver Specialists of Tidewater PLLC, in Norfolk, VA. In addition, Dr. Johnson currently serves as Professor of Medicine, Chief of Gastroenterology, in Eastern Virginia Medical School.
Dr. Johnson is Board-certified in Internal Medicine and Gastroenterology and is a past President of the American College of Gastroenterology, as well as a Master of the American College of Physicians. He has authored more than 600 papers in the field of gastroenterology.
Todd Patrick - DirectorMr. Patrick has been an independent member of the Board of Directors of CRH Medical since May 2006. In addition, Mr. Patrick currently serves as President/ Chief Executive Officer and member of the Board of Directors of C3J Therapeutics Inc.
Before joining C3J Therapeutics, Mr. Patrick was the President and Board member of ID Biomedical Corporation from 1994 until 2006, when the company was acquired by GlaxoSmithKline. Prior to ID Biomedical, Mr. Patrick was the Director of the Office of Intellectual Property Administration at the University of California, Los Angeles (UCLA), where he was responsible for the patenting and licensing of intellectual property arising out of UCLA.
Mr. Patrick has been involved in several start-ups and has helped raise over $600 million in equity or debt capital. He has participated in several mergers and acquisitions, including the sale of ID Biomedical for $1.7 billion.
Mr. Patrick holds a B.A. (Economics) from the University of Washington and a Master’s in Business Administration from Washington State University.
Mr. Patrick is member of the following Board of Directors Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.
Ian Webb - DirectorMr. Webb has been an independent member of the Board of Directors of CRH Medical since May 2006.
Mr. Webb is a retired partner of the law firm of Borden Ladner Gervais LLP, (“BLG”), where he practiced in the areas of corporate and securities law, with an emphasis on the legal requirements of public companies. He retired from BLG in 2010. Prior to joining CRH, Mr. Webb was also a member of the Board of Directors of ID Biomedical Corp.
Mr. Webb was admitted to the British Columbia bar in 1982, after graduating from Osgoode Hall Law School at York University with a Bachelor of Laws in 1981. Prior to that, he received a Master of Science in Theoretical Physics from the University of Saskatchewan in 1976.
Mr. Webb is member of the following Board of Directors Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.
Edward Wright - Chief Executive Officer, DirectorMr. Wright became CEO and director of the company in September of 2006. Prior to joining CRH he gained extensive management experience in global luxury brands at Richemont, the holding company for some of the world’s leading luxury goods. As President of Baume & Mercier first, and then as Executive Vice-President of North America Retail for Cartier, Mr. Wright developed an ability for building solid relationships with customers and business partners alike.
Upon arriving at CRH, Mr. Wright was tasked with maximizing the value of CRH’s O’Regan System. He quickly determined that CRH needed to transition from a retail model to a wholesale model and by introducing it to the gastrointestinal (“GI”) community in the US, he created a paradigm shift for gastrointestinal doctors (“GIs”) by extending their continuum of care for patients.
To maximize the value of CRH, Mr. Wright leveraged our relationships with the GI community leading to the launch of CRH Anesthesia Management, a business focused on providing GI anesthesia services to Ambulatory Surgical Centers (“ASCs”) across the US. CRH Anesthesia is now the primary driver of the company’s revenue and is positioned as one of the leading GI anesthesia brands in the US with outstanding growth potential.
Under Mr. Wright’s management CRH has become a profitable company with strong cash flow generation and access to North American capital markets to fund the company’s long-term growth strategy.
Mr. Wright is a member of the Young Presidents’ Organization and Chair of Vancouver College’s Board of Directors.